Literature DB >> 9972288

A myoglobin evolved from indoleamine 2,3-dioxygenase, a tryptophan-degrading enzyme.

T Suzuki1, H Kawamichi, K Imai.   

Abstract

The distribution, isolation, spectral and oxygen-binding properties, stability of ferrous state (autoxidation), amino acid sequence and gene structure of indoleamine 2,3-dioxygenase (IDO)-like myoglobins are summarized, and their evolution is discussed. Although it has long been thought that all hemoglobins and myoglobins have evolved from a common ancestral gene encoding a 14-16 kDa polypeptide, the discovery of IDO-like myoglobin from several gastropod molluscs clearly indicates that there was an alternative pathway for myoglobin evolution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9972288     DOI: 10.1016/s0305-0491(98)10086-x

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  5 in total

1.  NADH oxidase activity of indoleamine 2,3-dioxygenase.

Authors:  Federico I Rosell; Hsin H Kuo; A Grant Mauk
Journal:  J Biol Chem       Date:  2011-06-20       Impact factor: 5.157

Review 2.  The role of placental tryptophan catabolism.

Authors:  Peter Sedlmayr; Astrid Blaschitz; Roland Stocker
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

3.  Evolution of vertebrate indoleamine 2,3-dioxygenases.

Authors:  Hajime Julie Yuasa; Miwa Takubo; Ayumi Takahashi; Tetsuo Hasegawa; Hiroshi Noma; Tomohiko Suzuki
Journal:  J Mol Evol       Date:  2007-11-17       Impact factor: 2.395

4.  Crystallization and preliminary crystallographic studies of human indoleamine 2,3-dioxygenase.

Authors:  Shun-ichiro Oda; Hiroshi Sugimoto; Tadashi Yoshida; Yoshitsugu Shiro
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-02-10

Review 5.  Tryptophan-catabolizing enzymes - party of three.

Authors:  Helen J Ball; Felicita F Jusof; Supun M Bakmiwewa; Nicholas H Hunt; Hajime J Yuasa
Journal:  Front Immunol       Date:  2014-10-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.